NYSCF has been acquired by The Jackson Laboratory. Learn more

Cellular Dynamics Announces Commercial Launch of iCell(TM) Cardiomyocytes for Drug Candidate Toxicity Screening

Cellular Dynamics International, Press Release “MADISON, Wisc., Dec. 16, 2009 — Cellular Dynamic International (CDI) today announced the commercial...

Cellular Dynamics International, Press Release

“MADISON, Wisc., Dec. 16, 2009 — Cellular Dynamic International (CDI) today announced the commercial launch of iCellTM Cardiomyocytes for use in testing of new drug candidates by the pharmaceutical industry.”
Read More &raquo